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ABSTRACT: Herein is presented a rare example of salt/
cocrystal polymorphism involving the adduct between
ethionamide (ETH) and salicylic acid (SAL). Both the salt
and cocrystal forms have the same stoichiometry and
composition and are both stable at room temperature. The
synthetic procedure was successfully optimized in order to
selectively obtain both polymorphs. The two adducts’
structures were thoroughly investigated by means of single-
crystal X-ray diffraction, solid-state NMR spectroscopy, and
density functional theory (DFT) calculations. From the solid-
state NMR point of view, the combination of mono- and
multinuclear experiments (1H MAS, 13C and 15N CPMAS,
1H-{14N} D-HMQC, 1H−14N PM-S-RESPDOR) provided undoubted spectroscopic evidence about the different positions of
the hydrogen atom along the main N···H···O interaction. In particular, the 1H−14N PM-S-RESPDOR allowed N−H distance
measurements through the 1H detected signal at a very high spinning speed (70 kHz), which remarkably agree with those
derived by DFT optimized X-ray diffraction, even on a natural abundance real system. The thermodynamic relationship
between the salt and the cocrystal was inquired from the experimental and computational points of view, enabling the
characterization of the two polymorphs as enantiotropically related. The performances of the two forms in terms of dissolution
rate are comparable to each other but significantly higher with respect to the pure ETH.
■ INTRODUCTION
Crystal engineering has established itself as a valuable tool in
the design of functional molecular solids. In particular, tuning
physicochemical properties of a crystalline material by
changing the arrangement of its components, on the basis of
their molecular shapes and functional groups, is of outmost
importance in the pharmaceutical industry.1−3 Indeed, the
solubility, stability, bioavailability, and manufacturability of an
active pharmaceutical ingredient (API) can be properly
modified using different solid forms, such as polymorphs,
cocrystals, and salts.4−6 In particular, the latter two are
examples of multicomponent systems, namely, formed by the
API and a second GRAS (“generally recognized as safe”)
molecule, that are neutral in the case of cocrystals or ionic in
the case of salts. The distinction between these two types of
crystalline forms is crucial for pharmaceutical companies, not
only because they are often characterized by different
physicochemical and pharmacokinetic performances but also
from the legal and regulatory point of view, connected to
intellectual property issues.7−9 Furthermore, it is also
important under an academic perspective, related to the
study of structure−property relationships, molecular recog-
nition mechanisms, and weak interactions.9−13 In fact, in many
cases, the main distinction between salts and cocrystals
depends on whether a complete proton transfer has occurred
or not along the axis of a hydrogen bond (HB) interaction
between the API and the molecular partner.14 This will
generate ionized species in the former case and neutral ones in
the latter. Usually, a specific pair of molecules produces either
a salt or a cocrystal, although the neutral or ionic character of
the adduct can be modulated by temperature or stoichiom-
etry.15,16 However, to the best of our knowledge, there are only
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four examples in the literature in which the same chemical
species can crystallize both as a cocrystal and a salt with the
same composition and stoichiometry and at the same
temperature: tartaric acid−β-alanine,17 sulfamethazine−sac-
charin,18 isonicotinamide−citric acid,19 and dinitrobenzoic
acid−haloanilines.20 Only for the first three, the authors
managed to obtain the salt or cocrystal on purpose, while for
the fourth the achievement remained stochastic.
Here we present the ethionamide (ETH)−salicylic acid
(SAL) system, for which we managed to selectively drive the
synthesis toward both the salt (ETH+SAL−) and the cocrystal
(ETH·SAL) forms. ETH (Scheme 1, left) is an important
antitubercular drug, included in the Essential Medicine List by
the World Health Organization. Tuberculosis still represents
one of the most dangerous infective diseases, and new
therapies have continuously been investigated.21 ETH is an
analogue of isoniazid, and it is employed specifically for the
treatment of multidrug resistant tuberculosis (MDR-TB).22,23
Due to its limited water solubility (0.84 mg/mL),24 and
consequent unfavorable bioavailability, ETH has been
extensively investigated and a series of cocrystals and salts,
both organic and inorganic, have been reported.25−28 We
selected SAL (Scheme 1, right) as a coformer since ETH bears
a pyridine moiety and the pyridine−carboxylic acid hetero-
synthon is one of the most robust and reliable available
synthons.29,30 Furthermore, SAL is a GRAS phenolic acid with
analgesic and anti-inflammatory properties.31,32
In order to fully identify and characterize the structural
features of the two polymorphs, a complementary powder and
single-crystal X-ray diffraction (PXRD and SC-XRD, respec-
tively) and solid-state NMR (SSNMR) approach, supported by
DFT calculations, was employed. From the SSNMR point of
view, both common and advanced techniques (1H MAS, 13C
and 15N CPMAS, 1H-{14N} J- and D-HMQC, 1H−14N PM-S-
RESPDOR) were applied to discriminate between the neutral
or ionic nature of the adducts. In particular, the 1H−14N PM-
S-RESPDOR is a new sequence,33,34 which allows one to
determine 1H−14N distances through the 1H detected signal at
a very high spinning speed (70 kHz), and here it was tested on
a natural abundance real system.
The relative stability of the two polymorphs was assessed by
calorimetric analyses (DSC and TGA), competitive slurry
experiment, and DFT calculations, while inquiry of their
solubility properties was conducted by dissolution kinetic tests
(DKTs).
■ EXPERIMENTAL SECTION
SAL (purity > 99%) and all used solvents were purchased from Sigma-
Aldrich, while ETH (purity > 98%) was purchased from Alfa Aesar.
All reagents were used as received, without purification.
For ETH+SAL−, the bulk powder was achieved by kneading 50 mg
(0.3 mmol) of ETH and 42 mg (0.3 mmol) of SAL with a few drops
of MeOH for 20 min. Crystals suitable for SC-XRD were obtained
through seeding crystallization at room temperature of 5 mL of an
iPrOH−MeOH (1:3) solution using the bulk powder as seed.
For ETH·SAL, the bulk powder was prepared by employing a
rotavapor for rapid evaporation of 30 mL of a MeOH solution
containing 50 mg (0.3 mmol) of ETH and 42 mg (0.3 mmol) of SAL.
Single crystals were obtained by evaporation of a MeOH solution at
room temperature (5 mL).
For competitive slurry experiment, a mixture of 40 mg of ETH·SAL
and 40 mg of ETH+SAL− was stirred with a few milliliters of MeOH.
After 48 h, the resulting sample was filtered and analyzed by FTIR-
ATR (see Supporting Information Figure S17).
FTIR-ATR. FTIR-ATR spectra were collected on a Fourier
transform Equinox 55 (Bruker) spectrophotometer equipped with
an ATR device; the resolution was set at 2 cm−1 for all spectra. A
spectral range of 400−3800 cm−1 was scanned, using KBr as a beam
splitter. All spectra were acquired with 16 scans.
X-ray Diffraction. Single crystals of ETH·SAL and ETH+SAL−
were analyzed with a Gemini R Ultra diffractometer operating at
293(2) K, using a Mo Kα source (λ = 0.71073 Å). Data collection and
reduction were performed using the CrysAlisPro software.35 The
crystal structures were solved by direct methods and refined with the
full matrix least-squares technique on F2 using the SHELXS-97 and
SHELXL-97 programs.36,37 All non-hydrogen atoms were refined
anisotropically; hydrogen atoms bonded to unambiguous sites were
placed in geometrical positions and refined using the riding model.
Hydrogen atoms between pyridinic nitrogen and carboxylic oxygen
sites of nearby molecules were detected in the Fourier maps, and their
positions were checked through SSNMR. See Table 1 for the
crystallographic data of ETH+SAL− and ETH·SAL, and Tables S1a−
S4a and S1b−S4b in the Supporting Information for more details, i.e.,
bond distances and angles (refer to Scheme 1 in the main text for the
atom numbering). The powder diffractogram of ETH was obtained
Scheme 1. Chemical Structures of Ethionamide (ETH) and
Salicylic Acid (SAL), with Atom Numbering
Table 1. Crystallographic Data of ETH+SAL− and ETH·SAL
ETH+SAL− ETH·SAL
empirical formula C15H16N2O3S C15H16N2O3S
FW 304.36 304.36
temp/K 295 295
cryst syst monoclinic monoclinic












cryst size/mm3 0.34 × 0.22 × 0.21 0.35 × 0.34 × 0.22
radiation Mo Kα (λ = 0.71073) Mo Kα (λ = 0.71073)
2θ range for data
collection/deg
6.498−50.04 6.824−50.044
reflns collected 6564 6087
indepen reflns 2687 [Rint = 0.0510;
Rσ = 0.0674]
2742 [Rint = 0.0373;
Rσ = 0.0484]
data/restraints/params 2687/0/201 2742/0/203
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on the same Gemini R Ultra diffractometer, equipped with an X-ray
source using Cu Kα radiation (λ = 1.54 Å). Data were collected and
processed through the CrysAlisPro software. The powder patterns of
SAL, ETH·SAL, and ETH+SAL− were obtained on a Philips X’Pert
PW3020 Bragg−Brentano instrument, equipped with an X-ray source
using Cu Kα radiation (λ = 1.54506 Å) operating at 40 kV and 30
mA. Measurements were carried out in θ/2θ mode, with a scanning
range of 5−40° for 2θ.
SSNMR Measurements. All SSNMR measurements were
recorded at room temperature on a solid-state NMR spectrometer
(JNM-ECZ600R) at a magnetic field of 14.1 T, equipped with 3.2 or
1 mm 1H/X double-resonance probes, operating at 1H, 13C, 15N, and
14N Larmor frequencies of 600.1, 150.9, 60.8, and 43.4 MHz,
respectively. For 2D 1H-{14N} D-HMQC and PM-S-RESPDOR
experiments, ETH·SAL and ETH+SAL− were separately packed into 1
mm zirconia rotors and spun at a MAS frequency of 70 kHz. The 1H
radio frequency (rf) field for π/2 and π pulses was 208 kHz for
ETH+SAL− and 278 kHz for ETH·SAL,while it was 140 kHz for the
SR421 recoupling sequence for both samples. For D-HMQC
experiments, the 14N pulse length was 8 μs and the highest technically
possible rf power on 14N was used. The mixing time (τ) and recycling
delay were (171 μs; 20 s) and (342 μs; 25 s) for ETH+SAL− and
ETH·SAL, respectively. The two-dimensional 1H-{14N} D-HMQC
spectra were recorded with 24 scans, 32−42 t1 points, and rotor-
synchronized t1 increment of 14.3 μs. The dummy scans were 8 and 4
for ETH+SAL− and ETH·SAL, respectively. The states-TPPI method
was employed for the quadrature detection along the indirect
dimension. The experimental times were 11.2 h for ETH+SAL− and
10.7 h for ETH·SAL. For PM-S-RESPDOR experiments (performed
at JEOL Resonance Inc.), the length of the PM pulse was 10tR (0.14
ms) and the 14N rf field was 80 kHz (calibrated through NH4Cl) for
both samples. In order for the experiments to reach the steady state,
prior to the PM-S-RESPDOR measurements, 32 or 54 dummy scans
were applied on ETH+SAL− and ETH·SAL samples, respectively. The
mixing time (τ) was varied from 0 to 1.0 ms for ETH+SAL− and from
0 to 1.5 ms for ETH·SAL. The number of scans and recycling delays
were (32, 75 s) for ETH+SAL− and (36, 72 s) for ETH·SAL. The total
experimental times were 26 and 40 h for ETH+SAL− and ETH·SAL,
respectively. 1H MAS spectra were performed at 70 kHz with an echo
pulse sequence (90°−τ−180°−τ) to remove the probe background
(1H 90° pulse = 0.77 μs; three transients for all samples). 1D 13C
CPMAS and 15N CPMAS measurements were performed on
cylindrical 3.2 mm o.d. zirconia rotors with a sample volume of 60
μL spun at 20 (13C) and 12 kHz (15N). All experiments employed the
ramped CP pulse sequence with a 1H 90° pulse of 3.8 μs, a contact
time in the range of 3.5−4.5 ms, a number of scans in the range 325−
1150 for 13C spectra and 1253−13000 for 15N spectra, and a recycle
delay ranging between 4.2 and 12.5 s, depending on the sample. The
two-pulse phase modulation (TPPM) 1H decoupling scheme38 was
used for 13C, while SPINAL6439 was employed for 15N, both with a rf
field of 119 kHz. 1H, 13C, 14N, and 15N chemical shift scales were
referenced through the resonances of adamantane (1H signal at 1.87
ppm), glycine (13C methylene signal at 43.5 ppm), (NH4)2SO4 (
14N
signal at 0 ppm,and 15N signal at 24.6 ppm with respect to NH3),
respectively, which were used as external standards.
DFT Calculations. Periodic lattice calculations were performed
with Quantum Espresso version 6.4.1,40,41 adopting the nonlocal
vdW-DF2 method,42−48 choosing the b86r functional of Hamada.49
Geometry optimizations were performed starting from the solid-state
crystal structures, with a full geometry optimization with cell
relaxation. The relaxed cells are in substantial agreement with
experimental data, with volumes smaller than 4.6% and 4.8% for the
salt and the cocrystal, respectively. The PBE PAW pseudopotentials
from the PS Library 1.0.050 were adopted, with a cutoff of 60 Ry. The
Brillouin zones were automatically sampled with the Monkhorst−
Pack scheme51 in an approach similar to that previously described.52
Geometry optimizations were performed with grid meshes of 1 × 3 ×
1 and 1 × 2 × 1 for ETH·SAL and ETH+SAL−, respectively. The
energy difference between ETH+SAL− and ETH·SAL, in Rydberg,
was divided by 8, the number of molecules in the cell (i.e., Z) and
then converted into kJ/mol. Magnetic shieldings were calculated
using the GIPAW method,53 with a cutoff energy of 80 Ry. The
theoretical absolute 13C magnetic shielding (σ) values were converted
into the corresponding chemical shifts (δ) using the following
conversion: δcalc = σref − σ. Here, σref is the reference shielding,
obtained by plotting the experimental chemical shifts δexpt against the
GIPAW-calculated chemical shieldings (σ). A linear regression model
with slope constrained to (−1) was applied to find the best fit to the
data. The value of σref is determined by the intercept with the y
axis.54,55 The obtained values are 167.13 and 165.86 ppm for the salt
and cocrystal, respectively (see Figure S1).
Thermal Analyses. TGA measurements were performed over a
temperature range of 35−350 °C under a 50 mL·min−1 N2 flow, on a
Q600 SDT TA Instruments equipped with a DSC heat flow analyzer.
Samples (5−10 mg of weight) were placed into the furnace inside
alumina crucibles and heated with a ramp of 10 °C·min−1. DSC
curves were collected on a DSC Q200 TA Instrument. Samples were
accurately weighed (5−10 mg) and put into sealed aluminum pans.
Calibration for temperature and heat flow was performed using high
purity standards of n-decane, benzene, and indium. All measurements
were performed in a 40−130 °C temperature range, with heating rates
of 10 °C·min−1.
Dissolution Kinetic Tests. DKTs were carried out in phosphate
buffer (pH = 7.4). For each measurement, an equivalent amount of
solid to give 4 mg of ETH was added to 100 mL of the
thermostatically controlled (at 37 °C) dissolution medium. Each
test lasted 60 min. The solution was kept homogeneous by continued
stirring at 100 rpm, and concentrations were measured using an
optical fiber system (HELLMA, Milan, Italy) linked to a
spectrophotometer (ZEISS, Germany). UV measurements were
performed at the maximum absorption wavelength of ETH, namely,
288 nm. A calibration curve (Figure S2) was obtained with five
diluted ETH solutions in phosphate buffer (the concentrations used
were the following: 8, 10, 16, 20, and 40 mg/L), while pure phosphate
buffer was used as blank.
■ RESULTS AND DISCUSSION
Both the salt (ETH+SAL−) and the cocrystal (ETH·SAL)
forms of the ETH-SAL system were selectively obtained. The
salt was achieved by manual liquid-assisted grinding (LAG),
employing methanol, acetonitrile, dichloromethane, or n-
pentane as solvent. However, this easiness of formation in
the solid state was not reflected in solution, since many
crystallization trials at room temperature using a variety of
polar and apolar solvents failed in giving the compound (see
Table 2). On the contrary, at first the cocrystal stochastically
appeared while trying to crystallize the salt with methanol,
Table 2. List of the Different Solvents Employed in the Two
Preparation Methods, Liquid-Assisted Grinding (LAG) and
Solution Crystallization (SOL), and of the Corresponding
Productsa
solvent product (LAG) product (SOL)
methanol salt SM + cocrystal
ethanol salt SM + cocrystal







aAll SOL trials were conducted at room temperature. The products
were analyzed by FTIR-ATR (data not shown). SM stands for starting
materials.
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ethanol, or dichloromethane as solvents (see Table 2). To
obtain the pure bulk powder, rapid evaporation of a methanol
solution by means of a rotary evaporator was employed.56 The
large supersaturation generated this way ensured quantitative
precipitation of ETH·SAL. A competitive slurry experiment in
methanol at room temperature (see Figure S3 for the FTIR-
ATR spectra) confirmed that the salt is the thermodynamic
phase while the cocrystal is a kinetic product in these
conditions (see Thermal Analyses for further discussion).
Therefore, this system seems to follow the Oswald rule of
stages,57,58 which states that the less stable form tends to
crystallize first. It is also worth noting that the proton transfer
is not influenced by the character of the solvent, i.e., polar/
apolar or protic/aprotic. Actually, it is the method itself,
promoting either the kinetic or thermodynamic form, that
seems to determine the position of the hydrogen atom along
the main N···H···O interaction. Although simple grinding is
often employed to obtain thermodynamic polymorphs,59−61
LAG can generate different polymorphs upon changing the
solvent.62,63 In this case, however, all trials led to the same
thermodynamically stable polymorph.64
The outcome of the reaction between an acid and a base has
been historically proposed to be predictable, at least to a
certain degree, by employing the so-called “pKa rule”. Such rule
states that the larger the difference between the pKa values of
the two components, the greater the chance to obtain a salt
(vice versa, cocrystal is favored).65−67 According to a model
suggested by Cruz-Cabeza et al.,66 for −1 < ΔpKa < 4 the
probability of cocrystal or salt formation can be quantitatively
computed using the following formula: Pobs(AB)/% =
−17ΔpKa + 72 and Pobs(A−B+)/% = 17ΔpKa + 28,
respectively. As shown in Table 3, the ETH-SAL system well
fits in the pKa model, which calculates an almost equal chance
of salt and cocrystal formation. For the sake of comparison, the
same model was applied to the other examples of salt/cocrystal
polymorphism. It is apparent that all of the reported systems
fall in the region of uncertain prediction, with ΔpKa values
around 1. This is somewhat expected, since in this region there
is not a clear predominance of either salt or cocrystal
formation, meaning that both forms are theoretically
obtainable. Although the reported samples are not statistically
relevant, satisfying the pKa rule seems necessary to achieve
salt/cocrystal polymorphism. However, it is worth keeping in
mind that it is the crystalline environment as a whole that plays
a decisive role in defining the hydrogen position along an HB
at room temperature, as proposed by Childs and co-workers.67
The appearance of the new crystalline forms was confirmed
by different techniques, namely, FTIR-ATR (Figure S4 in the
Supporting Information), PXRD (Figures S5 and S6), and
solid-state NMR (SSNMR) (see below). The ionic or neutral
character of the products was investigated by SC-XRD,
supported by 15N CPMAS, 1H-{14N} D-HMQC, and N−H
distances measurements by 14N−1H PM-S-RESPDOR
SSNMR experiments, which account for very accurate
1H−14N distance values on natural abundance samples.33,34
For both forms, the comparison of the experimental and
calculated PXRD patterns (Figures S5 and S6) indicates that
the single-crystal structures are representative of the bulk
powders.
Crystal Structure Analysis. Yellow block-shaped crystals
of ETH+SAL−, suitable for SC-XRD, were obtained by
crystallization from an iPrOH−MeOH (1:3) solution with
the addition of a seed of the ground powder. It crystallizes in a
monoclinic P21/c space group (see Table S1a in the
Supporting Information) with one ETH cation and one SAL
anion in the asymmetric unit (Figure 1, top). The S1 sulfur is
disordered over two positions. The main intermolecular
interaction is the predicted charge-assisted heterosynthon
O9*···H−N1 (O9*···N1 = 2.592(4) Å), as shown by the
similar C−O distances of the carboxylate moiety (C7*−O8* =
1.234(4) Å and C7*−O9* = 1.278(3) Å), and the 14N−1H
distance by PM-S-RESPDOR SSNMR analysis (see below).
These distances are consistent with a proton transfer to the
ETH pyridinic nitrogen. A weaker HB is also observed
between the ETH thioamidic group as donor and a carboxylate
of a second SAL anion as acceptor (O8*···N8 = 2.868(4) Å).
This secondary HB interaction involving the SAL carboxylate,
which is absent in the cocrystal (see below), helps in favoring
the proton transfer and in stabilizing the charged species.68
The analysis of the crystal packing (Figure 1, middle)
highlights the presence of R4
4(22), tetrameric rings, formed
by pairs of ETH+SAL− units, and a contribution from π−π
stacking interactions (Figure 1, bottom) between contiguous
rings (intercentroid distances, 3.615(4) and 3.588(4) Å).
On the other hand, ETH·SAL, whose crystals were obtained
by crystallization from a MeOH solution, crystallizes in a
monoclinic P21/n space group. The asymmetric unit (Figure 2,
top) contains one ETH and one SAL molecule. The ETH
ethyl group shows disorder over two positions. The main
interaction still corresponds to the aforementioned O···N
heterosynthon, no longer charge-assisted (O9*···N1 =
2.646(4) Å) as shown by the larger difference between C−O
distances of the carboxylic moiety (C7*−O9* = 1.303(4) Å
Table 3. Cruz-Cabeza Model Applied on Examples of Salt−Cocrystal Polymorphism. (Pobs = Observed Probability)
adduct ΔpKaa Pobs(AB)/% Pobs(A−B+)/% expected product
ethionamide−salicylic acid 2b 38 62 salt or cocrystal
tartaric acid−β-alanine 0.63c,d 61.3 38.7 salt or cocrystal
sulfamethazine−saccharin 0.818 58.4 41.6 salt or cocrystal
isonicotinamide−citric acid 0.4e 65.2 34.8 salt or cocrystal
3,5-dinitrobenzoic acid−4-iodoaniline 0.9919 55.2 44.8 salt or cocrystal
3,5-dinitrobenzoic acid−4-bromoaniline 1.0719 53.8 46.2 salt or cocrystal
3,5-dinitrobenzoic acid−4-iodo-2-methylaniline 0.8419 57.7 42.3 salt or cocrystal
3,5-dinitrobenzoic acid−4-bromo-2-methylaniline 0.8919 56.9 43.1 salt or cocrystal
aΔpKa = pKa(protonated base) − pKa(acid). bpKa(ethionamide) = 5.0;24 pKa(salicylic acid) = 3.31 cpKa(β-alanine) = 3.63;76 pKa(tartaric acid) =
3.0.77 dFor β-alanine, the selected pKa value is relative to the carboxylic group. In fact, a careful analysis of the reported structures indicates that, in
the salt, the transferred proton is shared between the carboxylate moieties of two zwitterionic β-alanine molecules. epKa(isonicotinamide) = 3.45
78
(calculated); pKa(citric acid) = 3.05
78 (calculated).
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and C7*−O8* = 1.222(4) Å) and confirmed by the 14N−1H
distances measured by SSNMR (see below). These pieces of
evidence clearly indicate that, in this case, the proton transfer
does not occur. A further weaker HB involves the ETH
thioamidic group as donor and a hydroxyl oxygen of a second
SAL molecule as acceptor (O10*···N8 = 2.919(4) Å). The
tetrameric rings are substituted by spiral-shaped structures
(Figure 2, middle and bottom), due to the torsion of the
thioamidic moiety with respect to the ETH ring (C3−C4−
C7−N8 dihedral angle = −132°).
Solid-State NMR Characterization. A complete SSNMR
characterization (1H MAS, 13C and 15N CPMAS spectra, 2D
1H-{14N} D-HMQC spectra and 14N−1H PM-S-RESPDOR
experiments) was performed. All chemical shifts are listed in
Table S5, while the 1H MAS and 13C CPMAS spectra are
reported in Figures S7 and S8 in the Supporting Information.
The main evidence of the ionic/neutral nature of the
compounds is provided by 15N CPMAS spectra (Figure 3).
Indeed, pyridinic 15N chemical shift is recognized in being
particularly sensitive to its protonation state. For ETH+SAL−,
the N1 signal exhibits a marked shift of almost 100 ppm
toward lower frequencies (from 309.0 ppm for pure ETH
down to 211.9 ppm), consistent with a complete proton
transfer to the pyridinic nitrogen. For ETH·SAL, the low-
frequency shift is much less pronounced (from 309.0 to 273.4
ppm), indicating the formation of a neutral HB.69
This qualitative analysis is further expanded by 2D 1H-{14N}
D-HMQC spectra (Figure 4), which allow for the 1H
Figure 1. Asymmetric unit of ETH+SAL− represented by ellipsoids at 50% of probability, highlighting the main heterosynthon and the sulfur atom
disorder (top). Details of the tetrameric rings (middle) and the π−π stacking interactions (the disorder is removed for clarity) (middle and
bottom).
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assignment of the thioamidic N−H (H8) and pyridinic N+−H
or N···H (H9*) resonances as follows: at 10.8 (H8) and 18.4
ppm (H9*) for ETH+SAL− and at 10.3/8.7 (H8) and 17.3
ppm (H9*) for ETH·SAL (see Supporting Information for
further discussion).
Finally, the N−H distances were measured by 14N−1H PM-
S-RESPDOR SSNMR experiments, which provide very
accurate 1H−14N distances, leveraging the 1H detected signal
at a very high spinning speed (70 kHz). Details of the
experimental setup of the pulse sequence are given else-
where.33,34 In short, the method based on the PM-S-
RESPDOR sequence requires the acquisition of two sets of
data to extract the distance information. First, the experiment
is run without irradiation on the 14N channel, resulting in the
1H signal S0(τ). Second, the same experiment is run with the
14N PM pulse which prevents the refocusing of the 1H−14N
heteronuclear dipolar coupling, leading to the 1H signal S′(τ).
The PM-S-RESPDOR fraction curves are obtained by plotting
ΔS/S0 = (So(τ) − S′(τ))/So(τ)) as a function of mixing time,
τ. These fraction curves are then matched by analytical curves
where the dipolar coupling between 1H and 14N (b1H−14N/
(2π)) is the only fitting parameter. Once experimental and
analytical curves match, the extracted dipolar coupling























where γX (X =
1H or 14N) represents the gyromagnetic ratio of
the X nucleus.
Herein, the N−H distances are extracted by matching the
experimental and analytical fitting of ΔS/S0 fraction curves of
Figure 2. Asymmetric unit of ETH·SAL represented by ellipsoids at
50% of probability, highlighting the main heterosynthon and the ethyl
group disorder (top). Details of the packing and of the spiral-shaped
structures (the disorder is removed for clarity) (middle and bottom).
Figure 3. 15N (60.8 MHz) CPMAS spectra of ETH·SAL, ETH+SAL−,
and pure ETH with assignments, recorded at 12 kHz at room
temperature. The pyridinic nitrogen (N1) shift is highlighted, to mark
the different chemical shifts in the two polymorphs, with respect to
pure ETH.
Figure 4. 2D 1H-{14N} D-HMQC spectra (1H, 600.1 MHz; 14N, 43.4
MHz; νR = 70 kHz) of ETH
+SAL− (top) and ETH·SAL (bottom).
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the 1H signals of H9* at 18.4 (ETH+SAL−) and 17.3 ppm
(ETH·SAL), as assigned from the 2D 1H-{14N} D-HMQC
spectra. The extracted values were obtained by considering
mixing time (τ) values up to 0.4 and 1.0 ms for ETH+SAL−
and ETH·SAL, respectively. The experimental and simulated
ΔS/S0 fraction curves are represented in Figure 5 as black dots
and solid red lines, respectively. The best fittings are obtained
with N−H distances of 1.07 Å for ETH+SAL− and of 1.50 Å
for ETH·SAL. The same analysis was also carried out for the
NH2 group (
1H peaks at 10.8 and 10.3 ppm for ETH+SAL−
and ETH·SAL, respectively) for which the ΔS/S0 fraction
curves are reported in Figure S9, together with the obtained
N−H distances. These NMR distance values perfectly agree
with the reference mean values (1.128 Å for the salts; 1.491 Å
for the cocrystals) extrapolated from a CSD survey (CSD
version 5.40, updated in September 2019 on the N−H and N−
D distances of pyridine−carboxylic acid interactions in neutron
structures; see Figure S10 in the Supporting Information for
the 29 found structures).
DFT Calculations. We employed DFT-D nonlocal vdW-
df2-b86r method with a fully relaxed cell in order to optimize
the single-crystal structures (see Figures S11 and S12 for
superpositions). Our objective was 3-fold: (i) to support
chemical shift assignments by calculating chemical shieldings
and shifts; (ii) to obtain reference values for the N−H
distances and compare them to the SSNMR extrapolated ones;
(iii) to investigate the two polymorphs’ relative stability by
computing their lattice energy difference. The reliability of the
optimized structures is provided by the calculated chemical
shifts, which show agreement with the experimental ones,
displaying RMS values (for 13C) of 2.09, for the salt and 1.46,
for the cocrystal. The optimized N−H distances display values
of 1.087 and 1.488 Å for N+−H and N···H, respectively (see
Table 4), which again demonstrate the remarkable accuracy of
the PM-RESPDOR experiments. Finally, the DFT-D calcu-
lations indicate that the salt form has a lower lattice energy of
4.95 kJ/mol per molecule with respect the cocrystal. This
result, along with the higher density of the salt (salt = 1.332 g/
cm−3; cocrystal = 1.298 g/cm−3) confirms the stability
relationship derived by the competitive slurry and thermal
analysis (see below).
Thermal Analysis. A DSC run up to 130 °C was
conducted on the samples. As shown in Figure S13, both
forms display a melting point around 104 °C, while the salt
presents an additional broad endothermic event around 99 °C
due to salt−cocrystal polymorphic conversion. Indeed, the
FTIR-ATR spectrum of the salt sample after heating to 100 °C
matches the cocrystal one (Figure S14). Thus, the two phases
are enantiotropically related,70 with the salt being the most
stable one at room temperature. The cocrystal is kinetically
stable, as no reverse transitions are observed on cooling. If
compared to the melting point of pure ETH (around 165 °C),
it is apparent that the new adducts lead to a lower thermal
stability, as do almost all ETH multicomponent forms reported
in the literature.24−27 The TGA experiments do not show
weight loss before 150 °C, confirming that both adducts are
free from solvents (Figure S15).
Dissolution Kinetic Tests. DKTs were carried out in
water (pH 7.4 phosphate buffer) at 37 °C for both forms, to
evaluate the dissolution rate with respect to pure ETH (Figure
6). As expected, pure ETH exhibits a slow dissolution rate. On
the other hand, both salt and cocrystal display a pronounced
improvement, providing an ETH concentration of 32 mg/L,
which is reached in 24 min, while the concentration of pure
ETH after the same time is about 22 mg/L. Interestingly, both
ETH+SAL− and ETH·SAL show almost identical dissolution
profiles; i.e., the protonation state does not affect the overall in
vitro dissolution properties in agreement with previous
findings.67 A number of works have questioned the widespread
belief that pharmaceutical salts are more soluble than
cocrystals.71−74 All of these articles are based on systems
made by different components, i.e., one API and a series of
coformers, while our adducts are formed by the same
components, thus offering a decisive support to their claims.
Indeed, the complexity of the solubilization process cannot be
restricted to the position of a hydrogen along a single HB.
Figure 5. Experimental 14N−1H ΔS/S0 fraction curves (black dots)
achieved by PM-S-RESPDOR of (a) ETH+SAL− and (b) ETH·SAL
at 1H chemical shifts of 18.4 and 17.3 ppm, respectively, and analytical
fitting curves (red solid lines). The insets show the best fitting
1H−14N dipolar coupling on the basis of root-mean-square deviation
analysis.
Table 4. Comparison among N−H Distances Values from
Neutron Diffraction Structures (Mean Values), NMR, and
DFT Data
neutron diffraction/Å SSNMR/Å DFT-D/Å
ETH+SAL− 1.128 1.07 1.087
ETH·SAL 1.491 1.50 1.488
Figure 6. Dissolution profiles of (blue) ETH+SAL− and (green)
ETH·SAL, with respect to pure (orange) ETH. DKT were carried out
in water (pH 7.4 phosphate buffer) at 37 °C.
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In addition, more generally, a similar dissolution perform-
ance does not necessarily mean that other physicochemical
properties are the same. In fact, several examples showed that
cocrystals and salts display different properties. For instance,
Sandhu et al.75 reported that the hygroscopicity of a solid can
be significantly reduced through cocrystallization. Additionally,
in a structural analysis of over 80 cocrystals and salts, Aakeröy
et al.12 indicated that the frequency of solvate formation
among the salt forms was 19%, while such frequency reduced
to 5% in the case of cocrystals. While analyzing several
physicochemical properties such as hygroscopicity of
ETH+SAL− and ETH·SAL would be interesting for compar-
ison purposes, this type of information is beyond the scope of
the present study.
■ CONCLUSIONS
In conclusion, the ethionamide−salicylic acid system is a rare
example of salt/cocrystal polymorphism. The two forms have
the same stoichiometry and composition and are both stable at
room temperature, with the salt being the thermodynamic
phase and the cocrystal being the kinetic one. We managed to
optimize the synthetic procedure to selectively obtain both
forms. Thus, the method itself, promoting either the kinetic or
thermodynamic form, seems to determine the position of the
hydrogen atom along the main N···H···O interaction, rather
than the character of the solvent (protic/aprotic or polar/
apolar). We have unraveled the different ionic and neutral
character of the two polymorphs, by a combined X-ray
diffraction and SSNMR approach by leveraging the impressive
robustness of the PM-RESPDOR sequence for 1H−14N
distance measurements. Their thermodynamic relationship
was investigated from the experimental and computational
points of view, enabling one to characterize the two
polymorphs as enantiotropically related. The performances of
the two forms in terms of dissolution rate are comparable to
each other and significantly higher with respect to the pure
ETH. This is further evidence that packing, HBs, ionic or
neutral character, and dispersion forces are intimately
connected in determining the macroscopic properties of
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